KEY vs TMO · P/E 13, rev $7.51B vs P/E 24, rev $44.56B
KeyCorp (KEY) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
KeyCorp (KEY) is a banks - regional company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
KEY currently screens at market cap $22.64B and trailing P/E 12.8. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the KEY and TMO stock pages for the full models.
Not investment advice.